Where this grouping sits
Nested in
Inborn Errors of Immunity
Why this grouping
Grouped on the IUIS Table 2 pattern: combined immunodeficiency plus syndromic features beyond infection susceptibility alone. Members are kept as separate Disease entries because the primary genetic lesion and extravascular phenotype differ (22q11.2 deletion vs DNMT3B/ICF vs SP110 VODI vs NEMO/IKBKG ectodermal dysplasia). No MONDO mapping: IUIS Table 2 has no MONDO grouping class (MONDO:0015133 is an obsolete phagocyte-defect orphan; ectodermal dysplasia and immune deficiency subsume only EDA-ID members). Criteria are NECESSARY and, since the 2026-08 iuis_category backfill of Table 2 entries, fully auditable against the classifications block of every member.
Membership criteria
NECESSARY (member ⇒ criteria)
A disorder belongs to IUIS Table 2 if it is an IEI with combined immunodeficiency and prominent associated syndromic features (craniofacial, cardiac, ectodermal, or hematologic) that define the clinical entity.
- HAS CLASSIFICATION
Assigned to IUIS Table 2 (combined immunodeficiency with syndromic features) via classifications.iuis_category on the member Disease entry. Stated in the keyed `<slot>:<value>` form so the audit reads the structured classifications block.
Coverage and gaps
29 rows
Exact MONDO scope not assessed
29 listed with MONDO ID
No exact MONDO mapping is declared, so MONDO descendant gaps are not inferred for this grouping.
| Status | DisMech entry | MONDO concept | In DisMech | Has MONDO ID | In grouping MONDO | Member state | Conditions satisfied | C1.1 Assigned to IUIS Table 2 (combined immunodeficiency with syndromic features) via classifications.iuis_category on the member Disease entry. Stated in the keyed `<slot>:<value>` form so the audit reads the structured classifications block. |
|---|---|---|---|---|---|---|---|---|
| listed with MONDO ID |
22q11.2 Deletion Syndrome
DISEASE
Differentiating mechanismHemizygous 22q11.2 deletion (TBX1 haploinsufficiency and contiguous genes) causes DiGeorge spectrum disease with thymic hypoplasia, T-cell deficiency, conotruncal heart defects, and hypocalcemia.
TBX1 hgnc:11592
|
22q11.2 deletion syndrome
MONDO:0018923
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
ARPC1B Deficiency
DISEASE
Differentiating mechanismBiallelic ARPC1B loss removes the hematopoietically expressed isoform of the ARPC1 subunit of the Arp2/3 actin-branching complex, a lesion isoform redundancy cannot cover in blood cells. Thrombocytopenia with bleeding, eczema, recurrent infection, cutaneous vasculitis and raised IgA/IgE give a Wiskott-Aldrich-like actin defect reached one complex downstream of WASp.
ARPC1B hgnc:704
|
ARPC1B deficiency
MONDO:0060583
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Ataxia-telangiectasia
DISEASE
Differentiating mechanismBiallelic ATM loss cripples the kinase that orchestrates the DNA double-strand-break response, yielding progressive cerebellar neurodegeneration, oculocutaneous telangiectasia, cellular radiosensitivity and high malignancy risk alongside a variable combined immunodeficiency. The prototype of the Table 2 DNA-repair-defect subtable, spanning a continuum from classic childhood-onset disease to later-onset variant A-T with residual kinase activity.
ATM hgnc:795
|
Ataxia-telangiectasia
MONDO:0008840
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Autosomal Dominant Hyper-IgE Syndrome
DISEASE
Differentiating mechanismHeterozygous dominant-negative STAT3 poisons the obligate STAT3 dimer, collapsing transcriptional output across the IL-6/IL-11/IL-21/IL-23 network. The immune arm (Th17 failure, cold staphylococcal abscesses, pneumatoceles, extreme IgE) is inseparable from a non-immune connective-tissue, skeletal, dental and vascular syndrome — the defining Table 2 pattern, and the anchor of the hyper-IgE subtable.
STAT3 hgnc:11364
|
Autosomal Dominant Hyper-IgE Syndrome
MONDO:0007818
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Bloom syndrome
DISEASE
Differentiating mechanismBiallelic BLM loss removes the RecQ helicase that dissolves homologous-recombination intermediates without crossover, causing hyper-recombination with markedly increased sister-chromatid exchange as the diagnostic cellular readout. Severe pre- and postnatal growth deficiency, photosensitive facial rash and striking early multi-cancer predisposition dominate a phenotype in which the immunodeficiency is comparatively mild.
BLM hgnc:1058
|
Bloom syndrome
MONDO:0008876
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
CHARGE syndrome
DISEASE
Differentiating mechanismHeterozygous loss of the CHD7 chromatin remodeler perturbs neural crest-driven organogenesis — coloboma, heart defects, choanal atresia, semicircular canal hypoplasia, ear anomalies — and can include thymic hypoplasia with a DiGeorge-like T-cell deficiency, placing this multiple-anomaly disorder beside 22q11.2 deletion in the thymic-defect arm of Table 2.
CHD7 hgnc:20626
|
CHARGE syndrome
MONDO:0008965
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
T-cell Immunodeficiency, Congenital Alopecia, and Nail Dystrophy
DISEASE
Differentiating mechanismHuman nude SCID: biallelic FOXN1 loss prevents thymic epithelial cell differentiation, so no functional thymic microenvironment forms and athymia abolishes thymopoiesis. The same transcription factor acts in terminally differentiating skin epithelium, adding congenital alopecia and nail dystrophy — a two-organ lesion from one epithelial transcription factor, with the profoundest T-cell deficit in the grouping.
FOXN1 hgnc:12765
|
FOXN1 deficiency (nude SCID)
MONDO:0011132
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Hennekam lymphangiectasia-lymphedema syndrome 1
DISEASE
Differentiating mechanismBiallelic CCBE1 loss impairs VEGF-C-dependent lymphangiogenesis, producing generalized lymphatic dysplasia: intestinal lymphangiectasia with protein-losing enteropathy, peripheral and facial lymphedema, and intellectual disability. The immunodeficiency is attritional — hypogammaglobulinemia and lymphopenia from enteric loss of protein and lymphocytes rather than a lymphocyte-intrinsic defect.
CCBE1 hgnc:29426
|
Hennekam lymphangiectasia-lymphedema syndrome 1
MONDO:0009337
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Hennekam lymphangiectasia-lymphedema syndrome 2
DISEASE
Differentiating mechanismBiallelic FAT4 mutations in the giant atypical cadherin reproduce the Hennekam lymphangiectasia-lymphedema triad in CCBE1-mutation-negative families, reaching the same generalized lymphatic dysplasia through planar-cell-polarity signaling rather than the VEGF-C maturation axis of the CCBE1 form.
FAT4 hgnc:23109
|
Hennekam lymphangiectasia-lymphedema syndrome 2
MONDO:0014454
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
IKBKG ectodermal dysplasia with immunodeficiency
DISEASE
Differentiating mechanismX-linked NEMO (IKBKG) hypomorphic variants impair NF-kappaB signaling, causing ectodermal dysplasia with combined immunodeficiency and susceptibility to mycobacterial and pyogenic infections.
IKBKG hgnc:5961
|
IKBKG-related immunodeficiency with or without ectodermal dysplasia
MONDO:0100162
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Jacobsen Syndrome
DISEASE
Differentiating mechanismA contiguous-gene deletion of distal 11q (breakpoint at or telomeric to 11q23.3), not a single-gene lesion: haploinsufficiency across the deleted segment produces growth retardation, psychomotor delay, characteristic facies and Paris-Trousseau thrombocytopenia attributed to FLI1 haploinsufficiency, with variable antibody deficiency. With 22q11.2 deletion, one of the grouping's two chromosomal-deletion members carrying no single causal gene binding.
|
Jacobsen syndrome
MONDO:0007838
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Kabuki Syndrome
DISEASE
Differentiating mechanismHeterozygous KMT2D (less commonly KDM6A) variants impair epigenetic control of developmental gene expression, combining the characteristic facial gestalt, infantile hypotonia, intellectual disability and congenital heart disease with frequent humoral immune dysfunction and hypogammaglobulinemia — a chromatin-machinery member whose immune arm is B-cell rather than T-cell weighted.
KMT2D hgnc:7133
|
Kabuki syndrome
MONDO:0016512
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Loeys-Dietz Syndrome
DISEASE
Differentiating mechanismHeterozygous mutations in TGF-beta signaling components (most commonly TGFBR1/TGFBR2) cause the connective-tissue triad of arterial tortuosity and aneurysms, hypertelorism, and bifid uvula or cleft palate. Its immune arm is allergic dysregulation — food allergy and eosinophilic gastrointestinal disease — making it the vasculopathy-dominant member whose Table 2 listing rests on TGF-beta-driven immune skewing rather than lymphopenia.
TGFBR1 hgnc:11772
|
Loeys-Dietz syndrome
MONDO:0018954
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Netherton syndrome
DISEASE
Differentiating mechanismSPINK5 loss-of-function abolishes the serine-protease inhibitor LEKTI, unleashing kallikrein activity in the epidermis: congenital ichthyosis with bamboo-shaft hair, a defective skin barrier and prominent atopy. The grouping's skin-barrier member, where the syndromic surface disease rather than lymphocyte development carries the phenotype.
SPINK5 hgnc:15464
|
Netherton syndrome
MONDO:0009735
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Nijmegen breakage syndrome
DISEASE
Differentiating mechanismNBN (nibrin) defects disable the MRN double-strand-break sensor, producing chromosomal instability with delayed p53-mediated damage response and abnormal neurogenesis. Distinguished from its DNA-repair sibling ataxia-telangiectasia by progressive microcephaly and growth retardation rather than ataxia and telangiectasia, with immunodeficiency and marked lymphoma susceptibility.
NBN hgnc:7652
|
Nijmegen breakage syndrome
MONDO:0009623
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Roifman-syndrome
DISEASE
Differentiating mechanismBiallelic RNU4ATAC mutations disable the U4atac snRNA of the minor (U12-dependent) spliceosome, impairing splicing of a subset of essential genes. Antibody deficiency with recurrent infections combines with spondyloepiphyseal dysplasia, growth retardation and intellectual disability — with cartilage-hair hypoplasia, one of the grouping's non-coding-RNA lesions.
RNU4ATAC hgnc:34016
|
Roifman syndrome
MONDO:0014722
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
STAT6 Gain-of-Function Disease
DISEASE
Differentiating mechanismHeterozygous gain-of-function STAT6 amplifies IL-4/IL-13 type-2 signaling, producing early-onset severe allergic dysregulation with extreme IgE — a hyper-IgE-like syndromic presentation that IUIS groups with dominant-negative STAT3 rather than with the Table 4 dysregulation disorders. The only member here whose defining lesion is excess rather than loss of cytokine signal transduction, and one of the ten Table 2 entities newly recognized in the IUIS 2024 update.
STAT6 hgnc:11368
|
STAT6 gain-of-function disease
MONDO:0957807
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Schimke immuno-osseous dysplasia
DISEASE
Differentiating mechanismBiallelic SMARCAL1 loss removes the annealing helicase that restarts stalled replication forks; the resulting replication stress injures proliferative compartments selectively — growth-plate chondrocytes (spondyloepiphyseal dysplasia with short-trunk short stature), podocytes (steroid-resistant nephrotic syndrome) and lymphocytes (T-cell immunodeficiency). The grouping's immuno-osseous member alongside cartilage-hair hypoplasia, reached through genome maintenance rather than ribonucleoprotein biology.
SMARCAL1 hgnc:11102
|
Schimke immuno-osseous dysplasia
MONDO:0009458
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Vici Syndrome
DISEASE
Differentiating mechanismLoss of EPG5 blocks the late autophagosome-lysosome fusion step of macroautophagy. The immunodeficiency is one arm of a cardinal pentad (callosal agenesis, cataracts, oculocutaneous hypopigmentation, cardiomyopathy, combined immunodeficiency) — the only Table 2 member here whose syndromic breadth follows from a defect in a general catabolic pathway rather than a lymphocyte- or skeleton-specific one.
EPG5 hgnc:29331
|
Vici syndrome
MONDO:0009452
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Wiedemann-Steiner Syndrome
DISEASE
Differentiating mechanismHeterozygous KMT2A variants — usually de novo — disrupt the H3K4 methyltransferase of the epigenetic machinery, giving developmental delay, hypertrichosis cubiti, growth restriction and characteristic facies with variably present immune findings. The sibling chromatin-disorder to Kabuki syndrome, distinguished by its hypertrichosis and milder, more variable immunodeficiency.
KMT2A hgnc:7132
|
Wiedemann-Steiner syndrome
MONDO:0011518
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Wiskott-Aldrich syndrome
DISEASE
Differentiating mechanismX-linked loss or dysfunction of WASp, the hematopoietic actin regulator, disrupts cytoskeletal remodeling in leukocytes and platelets at once. The result pairs combined immunodeficiency and immune dysregulation with microthrombocytopenia, bleeding and eczema — the anchor of the Table 2 congenital-thrombocytopenia subtable — plus a marked lymphoid-malignancy excess.
WAS hgnc:12731
|
Wiskott-Aldrich syndrome
MONDO:0010518
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Cartilage-hair hypoplasia
DISEASE
Differentiating mechanismBiallelic variants in RMRP, a non-coding RNA rather than a protein, disable the RNase MRP endoribonuclease. One RNA-folding lesion reaches four organ systems at once (pre-rRNA processing, cyclin B2 mRNA cleavage, TERT partnering, small-RNA silencing), giving the immuno-osseous Table 2 pattern: metaphyseal chondrodysplasia and hypoplastic hair alongside combined immunodeficiency, anemia and a marked lymphoma excess.
RMRP hgnc:10031
|
cartilage-hair hypoplasia
MONDO:0009595
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Ectodermal Dysplasia and Immunodeficiency 2
DISEASE
Differentiating mechanismAutosomal recessive IKBA (NFKBIA) loss impairs NF-kappaB inhibitor function, causing ectodermal dysplasia with combined immunodeficiency (EDA-ID2) overlapping NEMO disease.
NFKBIA hgnc:7797
|
ectodermal dysplasia and immunodeficiency 2
MONDO:0012806
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Hepatic veno-occlusive disease-immunodeficiency syndrome
DISEASE
Differentiating mechanismBiallelic SP110 loss causes hepatic veno-occlusive disease with combined immunodeficiency and failure to control intracellular pathogens (VODI syndrome).
SP110 hgnc:5401
|
hepatic veno-occlusive disease-immunodeficiency syndrome
MONDO:0009338
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Immunodeficiency 80 with or without Congenital Cardiomyopathy
DISEASE
Differentiating mechanismBiallelic hypomorphic MCM10 variants impair the essential activator of the CMG replicative helicase; replication stress falls on the NK compartment (absent terminally mature NK cells with CMV susceptibility) or the fetal heart (congenital restrictive cardiomyopathy). Listed by IUIS in the Table 2 DNA-repair subsection beside GINS1 deficiency, which it phenocopies — reclassified here from the former innate-immunity-defect reading on 2026-08-26.
MCM10 hgnc:18043
|
immunodeficiency 80 with or without congenital cardiomyopathy
MONDO:0030266
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Immunodeficiency-Centromeric Instability-Facial Anomalies Syndrome
DISEASE
Differentiating mechanismDNMT3B, ZBTB24, or CDCA7 defects cause DNA hypomethylation with centromeric instability, facial dysmorphism, and progressive combined immunodeficiency (ICF syndrome).
DNMT3B hgnc:2979
|
immunodeficiency-centromeric instability-facial anomalies syndrome
MONDO:0000133
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Immunoskeletal Dysplasia with Neurodevelopmental Abnormalities
DISEASE
Differentiating mechanismHypomorphic biallelic EXTL3 alleles yield structurally aberrant heparan sulfate — longer chains, abnormal sulfation — rather than its absence. Because HS proteoglycans tune morphogen and cytokine signaling as co-receptors, one glycosyltransferase lesion is transduced in opposite directions by tissue, coupling spondyloepimetaphyseal dysplasia and neurodevelopmental disease to a T-cell-deficient combined immunodeficiency.
EXTL3 hgnc:3518
|
immunoskeletal dysplasia with neurodevelopmental abnormalities
MONDO:0044312
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Purine nucleoside phosphorylase deficiency
DISEASE
Differentiating mechanismAn inborn error of the purine salvage pathway: without PNP, deoxyguanosine accumulates and is phosphorylated to dGTP, a substrate-toxicity chain that falls preferentially on T cells. The only classical metabolic-enzyme member here, coupling a T-cell-predominant combined immunodeficiency to neurological disease and autoimmunity.
PNP hgnc:7892
|
purine nucleoside phosphorylase deficiency
MONDO:0013171
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Trichohepatoenteric Syndrome
DISEASE
Differentiating mechanismBiallelic TTC37 (or SKIV2L) variants disable the SKI complex, a cytoplasmic RNA-exosome cofactor for mRNA surveillance — a housekeeping lesion rather than intestine-specific machinery. Intractable congenital diarrhea, woolly hair, facial dysmorphism and liver disease combine with antibody deficiency in the defining trichohepatoenteric triad.
TTC37 hgnc:23639
|
trichohepatoenteric syndrome
MONDO:0009105
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
Source
View YAML on GitHubRaw YAML
name: Combined Immunodeficiency with Syndromic Features IEIs
display_name: Combined Immunodeficiency with Syndromic Features IEIs (IUIS Table 2)
creation_date: "2026-06-13T00:00:00Z"
description: >-
IUIS Table 2 — combined immunodeficiencies with associated or syndromic
features. These IEIs combine T- and/or B-cell immunodeficiency with
prominent developmental, craniofacial, ectodermal, hematologic, or
multi-organ syndromic findings that are part of the recognized clinical
spectrum.
grouping_basis:
- SHARED_MECHANISM
- SHARED_PHENOTYPE
grouping_rationale: >-
Grouped on the IUIS Table 2 pattern: combined immunodeficiency plus
syndromic features beyond infection susceptibility alone. Members are kept
as separate Disease entries because the primary genetic lesion and
extravascular phenotype differ (22q11.2 deletion vs DNMT3B/ICF vs SP110
VODI vs NEMO/IKBKG ectodermal dysplasia). No MONDO mapping: IUIS Table 2
has no MONDO grouping class (MONDO:0015133 is an obsolete phagocyte-defect
orphan; ectodermal dysplasia and immune deficiency subsume only EDA-ID
members). Criteria are NECESSARY and, since the 2026-08 iuis_category
backfill of Table 2 entries, fully auditable against the classifications
block of every member.
membership_criteria:
- description: >-
A disorder belongs to IUIS Table 2 if it is an IEI with combined
immunodeficiency and prominent associated syndromic features (craniofacial,
cardiac, ectodermal, or hematologic) that define the clinical entity.
criteria_semantics: NECESSARY
logic:
criterion_predicate: HAS_CLASSIFICATION
classification: "iuis_category:combined immunodeficiency with syndromic features"
description: >-
Assigned to IUIS Table 2 (combined immunodeficiency with syndromic
features) via classifications.iuis_category on the member Disease entry.
Stated in the keyed `<slot>:<value>` form so the audit reads the
structured classifications block.
members:
- member: 22q11.2 Deletion Syndrome
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Hemizygous 22q11.2 deletion (TBX1 haploinsufficiency and contiguous
genes) causes DiGeorge spectrum disease with thymic hypoplasia, T-cell
deficiency, conotruncal heart defects, and hypocalcemia.
gene:
preferred_term: TBX1
term:
id: hgnc:11592
label: TBX1
- member: Immunodeficiency-Centromeric Instability-Facial Anomalies Syndrome
member_type: DISEASE
differentiating_mechanisms:
- description: >-
DNMT3B, ZBTB24, or CDCA7 defects cause DNA hypomethylation with
centromeric instability, facial dysmorphism, and progressive combined
immunodeficiency (ICF syndrome).
gene:
preferred_term: DNMT3B
term:
id: hgnc:2979
label: DNMT3B
- member: Hepatic veno-occlusive disease-immunodeficiency syndrome
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Biallelic SP110 loss causes hepatic veno-occlusive disease with
combined immunodeficiency and failure to control intracellular
pathogens (VODI syndrome).
gene:
preferred_term: SP110
term:
id: hgnc:5401
label: SP110
- member: IKBKG ectodermal dysplasia with immunodeficiency
member_type: DISEASE
differentiating_mechanisms:
- description: >-
X-linked NEMO (IKBKG) hypomorphic variants impair NF-kappaB signaling,
causing ectodermal dysplasia with combined immunodeficiency and
susceptibility to mycobacterial and pyogenic infections.
gene:
preferred_term: IKBKG
term:
id: hgnc:5961
label: IKBKG
- member: Ectodermal Dysplasia and Immunodeficiency 2
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Autosomal recessive IKBA (NFKBIA) loss impairs NF-kappaB inhibitor
function, causing ectodermal dysplasia with combined immunodeficiency
(EDA-ID2) overlapping NEMO disease.
gene:
preferred_term: NFKBIA
term:
id: hgnc:7797
label: NFKBIA
- member: Autosomal Dominant Hyper-IgE Syndrome
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Heterozygous dominant-negative STAT3 poisons the obligate STAT3 dimer,
collapsing transcriptional output across the IL-6/IL-11/IL-21/IL-23
network. The immune arm (Th17 failure, cold staphylococcal abscesses,
pneumatoceles, extreme IgE) is inseparable from a non-immune
connective-tissue, skeletal, dental and vascular syndrome — the defining
Table 2 pattern, and the anchor of the hyper-IgE subtable.
gene:
preferred_term: STAT3
term:
id: hgnc:11364
label: STAT3
- member: Cartilage-hair hypoplasia
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Biallelic variants in RMRP, a non-coding RNA rather than a protein,
disable the RNase MRP endoribonuclease. One RNA-folding lesion reaches
four organ systems at once (pre-rRNA processing, cyclin B2 mRNA cleavage,
TERT partnering, small-RNA silencing), giving the immuno-osseous Table 2
pattern: metaphyseal chondrodysplasia and hypoplastic hair alongside
combined immunodeficiency, anemia and a marked lymphoma excess.
gene:
preferred_term: RMRP
term:
id: hgnc:10031
label: RMRP
- member: Immunoskeletal Dysplasia with Neurodevelopmental Abnormalities
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Hypomorphic biallelic EXTL3 alleles yield structurally aberrant heparan
sulfate — longer chains, abnormal sulfation — rather than its absence.
Because HS proteoglycans tune morphogen and cytokine signaling as
co-receptors, one glycosyltransferase lesion is transduced in opposite
directions by tissue, coupling spondyloepimetaphyseal dysplasia and
neurodevelopmental disease to a T-cell-deficient combined
immunodeficiency.
gene:
preferred_term: EXTL3
term:
id: hgnc:3518
label: EXTL3
- member: Vici Syndrome
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Loss of EPG5 blocks the late autophagosome-lysosome fusion step of
macroautophagy. The immunodeficiency is one arm of a cardinal pentad
(callosal agenesis, cataracts, oculocutaneous hypopigmentation,
cardiomyopathy, combined immunodeficiency) — the only Table 2 member
here whose syndromic breadth follows from a defect in a general
catabolic pathway rather than a lymphocyte- or skeleton-specific one.
gene:
preferred_term: EPG5
term:
id: hgnc:29331
label: EPG5
- member: STAT6 Gain-of-Function Disease
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Heterozygous gain-of-function STAT6 amplifies IL-4/IL-13 type-2 signaling,
producing early-onset severe allergic dysregulation with extreme IgE — a
hyper-IgE-like syndromic presentation that IUIS groups with
dominant-negative STAT3 rather than with the Table 4 dysregulation
disorders. The only member here whose defining lesion is excess rather
than loss of cytokine signal transduction, and one of the ten Table 2
entities newly recognized in the IUIS 2024 update.
gene:
preferred_term: STAT6
term:
id: hgnc:11368
label: STAT6
- member: Wiskott-Aldrich syndrome
member_type: DISEASE
differentiating_mechanisms:
- description: >-
X-linked loss or dysfunction of WASp, the hematopoietic actin regulator,
disrupts cytoskeletal remodeling in leukocytes and platelets at once.
The result pairs combined immunodeficiency and immune dysregulation with
microthrombocytopenia, bleeding and eczema — the anchor of the Table 2
congenital-thrombocytopenia subtable — plus a marked lymphoid-malignancy
excess.
gene:
preferred_term: WAS
term:
id: hgnc:12731
label: WAS
- member: Ataxia-telangiectasia
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Biallelic ATM loss cripples the kinase that orchestrates the DNA
double-strand-break response, yielding progressive cerebellar
neurodegeneration, oculocutaneous telangiectasia, cellular
radiosensitivity and high malignancy risk alongside a variable combined
immunodeficiency. The prototype of the Table 2 DNA-repair-defect
subtable, spanning a continuum from classic childhood-onset disease to
later-onset variant A-T with residual kinase activity.
gene:
preferred_term: ATM
term:
id: hgnc:795
label: ATM
- member: Nijmegen breakage syndrome
member_type: DISEASE
differentiating_mechanisms:
- description: >-
NBN (nibrin) defects disable the MRN double-strand-break sensor,
producing chromosomal instability with delayed p53-mediated damage
response and abnormal neurogenesis. Distinguished from its DNA-repair
sibling ataxia-telangiectasia by progressive microcephaly and growth
retardation rather than ataxia and telangiectasia, with
immunodeficiency and marked lymphoma susceptibility.
gene:
preferred_term: NBN
term:
id: hgnc:7652
label: NBN
- member: Bloom syndrome
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Biallelic BLM loss removes the RecQ helicase that dissolves
homologous-recombination intermediates without crossover, causing
hyper-recombination with markedly increased sister-chromatid exchange as
the diagnostic cellular readout. Severe pre- and postnatal growth
deficiency, photosensitive facial rash and striking early multi-cancer
predisposition dominate a phenotype in which the immunodeficiency is
comparatively mild.
gene:
preferred_term: BLM
term:
id: hgnc:1058
label: BLM
- member: Purine nucleoside phosphorylase deficiency
member_type: DISEASE
differentiating_mechanisms:
- description: >-
An inborn error of the purine salvage pathway: without PNP,
deoxyguanosine accumulates and is phosphorylated to dGTP, a
substrate-toxicity chain that falls preferentially on T cells. The only
classical metabolic-enzyme member here, coupling a T-cell-predominant
combined immunodeficiency to neurological disease and autoimmunity.
gene:
preferred_term: PNP
term:
id: hgnc:7892
label: PNP
- member: CHARGE syndrome
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Heterozygous loss of the CHD7 chromatin remodeler perturbs neural
crest-driven organogenesis — coloboma, heart defects, choanal atresia,
semicircular canal hypoplasia, ear anomalies — and can include thymic
hypoplasia with a DiGeorge-like T-cell deficiency, placing this
multiple-anomaly disorder beside 22q11.2 deletion in the
thymic-defect arm of Table 2.
gene:
preferred_term: CHD7
term:
id: hgnc:20626
label: CHD7
- member: Jacobsen Syndrome
member_type: DISEASE
differentiating_mechanisms:
- description: >-
A contiguous-gene deletion of distal 11q (breakpoint at or telomeric to
11q23.3), not a single-gene lesion: haploinsufficiency across the
deleted segment produces growth retardation, psychomotor delay,
characteristic facies and Paris-Trousseau thrombocytopenia attributed to
FLI1 haploinsufficiency, with variable antibody deficiency. With
22q11.2 deletion, one of the grouping's two chromosomal-deletion members
carrying no single causal gene binding.
- member: Roifman-syndrome
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Biallelic RNU4ATAC mutations disable the U4atac snRNA of the minor
(U12-dependent) spliceosome, impairing splicing of a subset of essential
genes. Antibody deficiency with recurrent infections combines with
spondyloepiphyseal dysplasia, growth retardation and intellectual
disability — with cartilage-hair hypoplasia, one of the grouping's
non-coding-RNA lesions.
gene:
preferred_term: RNU4ATAC
term:
id: hgnc:34016
label: RNU4ATAC
- member: Loeys-Dietz Syndrome
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Heterozygous mutations in TGF-beta signaling components (most commonly
TGFBR1/TGFBR2) cause the connective-tissue triad of arterial tortuosity
and aneurysms, hypertelorism, and bifid uvula or cleft palate. Its
immune arm is allergic dysregulation — food allergy and eosinophilic
gastrointestinal disease — making it the vasculopathy-dominant member
whose Table 2 listing rests on TGF-beta-driven immune skewing rather
than lymphopenia.
gene:
preferred_term: TGFBR1
term:
id: hgnc:11772
label: TGFBR1
- member: Netherton syndrome
member_type: DISEASE
differentiating_mechanisms:
- description: >-
SPINK5 loss-of-function abolishes the serine-protease inhibitor LEKTI,
unleashing kallikrein activity in the epidermis: congenital ichthyosis
with bamboo-shaft hair, a defective skin barrier and prominent atopy.
The grouping's skin-barrier member, where the syndromic surface disease
rather than lymphocyte development carries the phenotype.
gene:
preferred_term: SPINK5
term:
id: hgnc:15464
label: SPINK5
- member: Trichohepatoenteric Syndrome
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Biallelic TTC37 (or SKIV2L) variants disable the SKI complex, a
cytoplasmic RNA-exosome cofactor for mRNA surveillance — a housekeeping
lesion rather than intestine-specific machinery. Intractable congenital
diarrhea, woolly hair, facial dysmorphism and liver disease combine
with antibody deficiency in the defining trichohepatoenteric triad.
gene:
preferred_term: TTC37
term:
id: hgnc:23639
label: TTC37
- member: Hennekam lymphangiectasia-lymphedema syndrome 1
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Biallelic CCBE1 loss impairs VEGF-C-dependent lymphangiogenesis,
producing generalized lymphatic dysplasia: intestinal lymphangiectasia
with protein-losing enteropathy, peripheral and facial lymphedema, and
intellectual disability. The immunodeficiency is attritional —
hypogammaglobulinemia and lymphopenia from enteric loss of protein and
lymphocytes rather than a lymphocyte-intrinsic defect.
gene:
preferred_term: CCBE1
term:
id: hgnc:29426
label: CCBE1
- member: Hennekam lymphangiectasia-lymphedema syndrome 2
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Biallelic FAT4 mutations in the giant atypical cadherin reproduce the
Hennekam lymphangiectasia-lymphedema triad in CCBE1-mutation-negative
families, reaching the same generalized lymphatic dysplasia through
planar-cell-polarity signaling rather than the VEGF-C maturation axis
of the CCBE1 form.
gene:
preferred_term: FAT4
term:
id: hgnc:23109
label: FAT4
- member: Kabuki Syndrome
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Heterozygous KMT2D (less commonly KDM6A) variants impair epigenetic
control of developmental gene expression, combining the characteristic
facial gestalt, infantile hypotonia, intellectual disability and
congenital heart disease with frequent humoral immune dysfunction and
hypogammaglobulinemia — a chromatin-machinery member whose immune arm
is B-cell rather than T-cell weighted.
gene:
preferred_term: KMT2D
term:
id: hgnc:7133
label: KMT2D
- member: Wiedemann-Steiner Syndrome
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Heterozygous KMT2A variants — usually de novo — disrupt the H3K4
methyltransferase of the epigenetic machinery, giving developmental
delay, hypertrichosis cubiti, growth restriction and characteristic
facies with variably present immune findings. The sibling
chromatin-disorder to Kabuki syndrome, distinguished by its
hypertrichosis and milder, more variable immunodeficiency.
gene:
preferred_term: KMT2A
term:
id: hgnc:7132
label: KMT2A
- member: Immunodeficiency 80 with or without Congenital Cardiomyopathy
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Biallelic hypomorphic MCM10 variants impair the essential activator of
the CMG replicative helicase; replication stress falls on the NK
compartment (absent terminally mature NK cells with CMV susceptibility)
or the fetal heart (congenital restrictive cardiomyopathy). Listed by
IUIS in the Table 2 DNA-repair subsection beside GINS1 deficiency,
which it phenocopies — reclassified here from the former
innate-immunity-defect reading on 2026-08-26.
gene:
preferred_term: MCM10
term:
id: hgnc:18043
label: MCM10
- member: Schimke immuno-osseous dysplasia
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Biallelic SMARCAL1 loss removes the annealing helicase that restarts
stalled replication forks; the resulting replication stress injures
proliferative compartments selectively — growth-plate chondrocytes
(spondyloepiphyseal dysplasia with short-trunk short stature),
podocytes (steroid-resistant nephrotic syndrome) and lymphocytes
(T-cell immunodeficiency). The grouping's immuno-osseous member
alongside cartilage-hair hypoplasia, reached through genome maintenance
rather than ribonucleoprotein biology.
gene:
preferred_term: SMARCAL1
term:
id: hgnc:11102
label: SMARCAL1
- member: T-cell Immunodeficiency, Congenital Alopecia, and Nail Dystrophy
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Human nude SCID: biallelic FOXN1 loss prevents thymic epithelial cell
differentiation, so no functional thymic microenvironment forms and
athymia abolishes thymopoiesis. The same transcription factor acts in
terminally differentiating skin epithelium, adding congenital alopecia
and nail dystrophy — a two-organ lesion from one epithelial
transcription factor, with the profoundest T-cell deficit in the
grouping.
gene:
preferred_term: FOXN1
term:
id: hgnc:12765
label: FOXN1
- member: ARPC1B Deficiency
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Biallelic ARPC1B loss removes the hematopoietically expressed isoform
of the ARPC1 subunit of the Arp2/3 actin-branching complex, a lesion
isoform redundancy cannot cover in blood cells. Thrombocytopenia with
bleeding, eczema, recurrent infection, cutaneous vasculitis and raised
IgA/IgE give a Wiskott-Aldrich-like actin defect reached one complex
downstream of WASp.
gene:
preferred_term: ARPC1B
term:
id: hgnc:704
label: ARPC1B
notes: >-
Intentionally unmapped to MONDO. Audit with
`uv run python scripts/grouping_mondo_gaps.py --grouping "Inborn"`.
STAT6 Gain-of-Function Disease was reclassified from IUIS Table 4 to Table 2
on 2026-08-20 and newly listed here: the IUIS 2024 update lists STAT6 (AD GOF)
under combined immunodeficiencies with syndromic features, Table 2 subtable 1
(PMID:41608114). Its allergic/type-2 phenotype had previously been read as a
Table 4 signal. It had never been listed as a member of the Immune
Dysregulation IEIs grouping — only its `iuis_category` carried the Table 4
assignment — so this is a first listing, not a transfer between member lists.
2026-08-29 membership sync: the member list was brought in line with the
entries carrying `iuis_category: combined immunodeficiency with syndromic
features` after the IUIS Table 2 classification backfill, growing from 10 to
29 members (19 added: Wiskott-Aldrich, ataxia-telangiectasia, Nijmegen
breakage, Bloom, PNP deficiency, CHARGE, Jacobsen, Roifman, Loeys-Dietz,
Netherton, trichohepatoenteric, Hennekam 1 and 2, Kabuki, Wiedemann-Steiner,
IMD80/MCM10, Schimke immuno-osseous dysplasia, FOXN1 nude SCID, and ARPC1B
deficiency). IMD80 entered via its 2026-08-26 reclassification from `innate
immunity defect` (the IUIS 2022 update lists MCM10 only in Table 2, beside
GINS1 deficiency). Jacobsen syndrome is a contiguous-gene chromosomal
deletion of distal 11q with no single causal gene, so its differentiating
mechanism carries no gene binding (unlike 22q11.2 deletion, whose block
names TBX1 as the major haploinsufficient driver).